LGD-6972

DRUG2 trials

Sponsors

Ligand Pharmaceuticals

Conditions

Type 2 Diabetes Mellitus

Phase 1

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus

CompletedNCT01919684

Ligand PharmaceuticalsType 2 Diabetes Mellitus

Start: 2013-11-30End: 2014-03-31Updated: 2014-09-25

Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus

CompletedNCT02250222

Ligand PharmaceuticalsType 2 Diabetes Mellitus

Start: 2014-10-31End: 2015-06-30Updated: 2015-06-11